Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
4 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Efficacy and safety of GP40021 insulin lispro biphasic compared with Humalog Mix 25 in Type 2 diabetes mellitus patients.
J Comp Eff Res. 2021 Jan;10(1):55-66. doi: 10.2217/cer-2020-0064. Epub 2020 Dec 23.
J Comp Eff Res. 2021.
PMID: 33355484
Free article.
Clinical Trial.
Modeling of Pharmacokinetic Profiles of Insulin Aspart and Biphasic Insulin Aspart 30/70.
Kulesh VS, Drai RV, Zinnatulina BR, Makarenko IE, Pilyus FG, Khokhlov AL.
Kulesh VS, et al. Among authors: zinnatulina br.
J Clin Pharmacol. 2022 Sep;62(9):1086-1093. doi: 10.1002/jcph.2049. Epub 2022 Apr 17.
J Clin Pharmacol. 2022.
PMID: 35320591
Item in Clipboard
PKPD Modeling and Simulations to Support Biosimilar Development of Biphasic Insulin Aspart 30.
Petrov AV, Zinnatulina BR, Drai RV, Karonova TL, Koksharova EO, Dorotenko AR, Makarenko IE.
Petrov AV, et al. Among authors: zinnatulina br.
Clin Pharmacol Drug Dev. 2022 Dec;11(12):1457-1466. doi: 10.1002/cpdd.1152. Epub 2022 Aug 18.
Clin Pharmacol Drug Dev. 2022.
PMID: 35980375
Item in Clipboard
The efficacy and safety of GP40081 (insulin aspart biphasic 30) compared with NovoMix® 30 in Type 2 diabetes patients.
Drai RV, Mayorov AY, Karonova TL, Parfenova TM, Makarenko IE, Magruk MA, Alpenidze DN, Kovalik VV, Zinnatulina BR, Grigorjeva IV, Andreeva AT.
Drai RV, et al. Among authors: zinnatulina br.
J Comp Eff Res. 2022 Dec;11(18):1337-1347. doi: 10.2217/cer-2021-0232. Epub 2022 Dec 13.
J Comp Eff Res. 2022.
PMID: 36511777
Free article.
Clinical Trial.
Item in Clipboard
Cite
Cite